Vonoprazan fumarate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for vonoprazan fumarate and what is the scope of freedom to operate?
Vonoprazan fumarate
is the generic ingredient in one branded drug marketed by Phathom and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Vonoprazan fumarate has one hundred and three patent family members in forty-three countries.
There is one drug master file entry for vonoprazan fumarate. One supplier is listed for this compound.
Summary for vonoprazan fumarate
International Patents: | 103 |
US Patents: | 2 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 7 |
What excipients (inactive ingredients) are in vonoprazan fumarate? | vonoprazan fumarate excipients list |
DailyMed Link: | vonoprazan fumarate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for vonoprazan fumarate
Generic Entry Date for vonoprazan fumarate*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for vonoprazan fumarate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 |
The First Affiliated Hospital of Nanchang University | Phase 4 |
Nanhai Hospital, Southern Medical University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for vonoprazan fumarate
US Patents and Regulatory Information for vonoprazan fumarate
International Patents for vonoprazan fumarate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Malaysia | 169461 | PHARMACEUTICAL COMPOSITION | ⤷ Try a Trial |
Argentina | 072842 | COMPOSICION FARMACEUTICA ESTABILIZADA QUE COMPRENDE UN INGREDIENTE FARMACEUTICAMENTE ACTIVO NO PEPTIDICO | ⤷ Try a Trial |
Montenegro | 00610 | 1 -HETEROCIKLILSULFONIL, 2 -AMINOMETIL, 5- (HETERO-) ARIL SUPSTITUISAN 1-H-PIROL DERIVATI KAO INHIBITORI LUČENJA KISELINE (1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS) | ⤷ Try a Trial |
Spain | 2669592 | ⤷ Try a Trial | |
Poland | 2327692 | ⤷ Try a Trial | |
Japan | 5204426 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |